Publications:

Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy.

Mabs

Waldhauer, Inja I; Gonzalez-Nicolini, Valeria V; Freimoser-Grundschober, Anne A; Nayak, Tapan K TK; Fahrni, Linda L; Hosse, Ralf J RJ; Gerrits, Danny D; Geven, Edwin J W EJW; Sam, Johannes J; Lang, Sabine S; Bommer, Esther E; Steinhart, Virginie V; Husar, Elisabeth E; Colombetti, Sara S; Van Puijenbroek, Erwin E; Neubauer, Markus M; Cline, J Mark JM; Garg, Pradeep K PK; Dugan, Gregory G; Cavallo, Federica F; Acuna, Gonzalo G; Charo, Jehad J; Teichgräber, Volker V; Evers, Stefan S; Boerman, Otto C OC; Bacac, Marina M; Moessner, Ekkehard E; Umaña, Pablo P; Klein, Christian C

Publication Date: 2021

Variant appearance in text: APC: L72G

PubMed Link: 33974508

Variant Present in the following documents:

• Main text

View BVdb publication page

Effects of interleukin-2 in immunostimulation and immunosuppression.

The Journal Of Experimental Medicine

Pol, Jonathan G JG; Caudana, Pamela P; Paillet, Juliette J; Piaggio, Eliane E; Kroemer, Guido G

Publication Date: 2020-01-06

Variant appearance in text: APC: L72G

PubMed Link: 31611250

Variant Present in the following documents:

• Main text

View BVdb publication page